Emmanuelle Cottreel
Roche (Switzerland)(CH)
Publications by Year
Research Areas
Pulmonary Hypertension Research and Treatments, Sleep and Wakefulness Research, Photochromic and Fluorescence Chemistry, Liver Disease and Transplantation, Neuroscience and Neuropharmacology Research
Most-Cited Works
- → Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial(2019)175 cited
- → Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis: A Multicenter, Prospective Cohort Study(2016)152 cited
- → The REPAIR Study(2021)52 cited
- → TLR7 agonist RO7020531 versus placebo in healthy volunteers and patients with chronic hepatitis B virus infection: a randomised, observer-blind, placebo-controlled, phase 1 trial(2022)39 cited
- → Substituted pyrrolidin-2-ones: Centrally acting orexin receptor antagonists promoting sleep. Part 2(2015)34 cited
- → Macitentan Improves Risk Categorization for Liver Transplant Mortality in Patients With Portopulmonary Hypertension: A PORTICO Study Post Hoc Analysis(2020)24 cited
- → Novel pyrazolo-tetrahydropyridines as potent orexin receptor antagonists(2010)17 cited
- → Discovery of substituted lactams as novel dual orexin receptor antagonists. Synthesis, preliminary structure–activity relationship studies and efforts towards improved metabolic stability and pharmacokinetic properties. Part 1(2014)17 cited
- → Structure–activity relationship studies and sleep-promoting activity of novel 1-chloro-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine derivatives as dual orexin receptor antagonists. Part 2(2013)13 cited
- → Synthesis, structure–activity relationship studies, and identification of novel 5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine derivatives as dual orexin receptor antagonists. Part 1(2013)12 cited